Prognostic factors affecting overall survival, multivariate analysis including IPI categories
| Variables . | Multivariate . | Multivariate (final model) . | ||
|---|---|---|---|---|
| Relative risk (95% CI) . | P . | Relative risk (95% CI) . | P . | |
| Comparison with risk factors | ||||
| CD5 status | 1.11 (0.83-1.49) | .49 | — | — |
| Age | 1.85 (1.40-2.45) | .000016 | 1.89 (1.43-2.50) | .0000082 |
| Performance status | 1.82 (1.34-2.46) | .00012 | 1.90 (1.40-2.57) | .000034 |
| LDH | 1.86 (1.38-2.53) | .000057 | 1.90 (1.41-2.57) | .000029 |
| Stage | 1.73 (1.24-2.39) | .0011 | 1.92 (1.42-2.58) | .000019 |
| Extranodal disease | 1.27 (0.94-1.72) | .12 | — | — |
| Comparison with IPI category | ||||
| CD5 status | — | — | 1.31 (0.98-1.77) | .068 |
| IPI | — | — | 3.84 (2.96-4.97) | < .0000001 |
| Variables . | Multivariate . | Multivariate (final model) . | ||
|---|---|---|---|---|
| Relative risk (95% CI) . | P . | Relative risk (95% CI) . | P . | |
| Comparison with risk factors | ||||
| CD5 status | 1.11 (0.83-1.49) | .49 | — | — |
| Age | 1.85 (1.40-2.45) | .000016 | 1.89 (1.43-2.50) | .0000082 |
| Performance status | 1.82 (1.34-2.46) | .00012 | 1.90 (1.40-2.57) | .000034 |
| LDH | 1.86 (1.38-2.53) | .000057 | 1.90 (1.41-2.57) | .000029 |
| Stage | 1.73 (1.24-2.39) | .0011 | 1.92 (1.42-2.58) | .000019 |
| Extranodal disease | 1.27 (0.94-1.72) | .12 | — | — |
| Comparison with IPI category | ||||
| CD5 status | — | — | 1.31 (0.98-1.77) | .068 |
| IPI | — | — | 3.84 (2.96-4.97) | < .0000001 |
CI indicates confidence interval.